Copper-Mediated C─H Amination of Hetero (Arene) Scaffolds via Amide Directing Group: Unlocking Bioactive Pharmacophore for Next-Generation Drug Discovery.
TL;DR
The pivotal role of copper is underscores in advancing next-generation, sustainable synthetic methodologies and inspiring future innovations in amine-based drug discovery by bridging the disciplines of transition-based synthesis and medicinal chemistry.
Abstract
Copper-mediated C─H amination has emerged as a powerful and sustainable strategy for constructing nitrogen-containing bioactive scaffolds, providing an efficient alternative to traditional cross-coupling methodologies. Historically, precious metals have dominated C─H amination chemistry but often suffer from limitations, including high cost, toxicity, and limited availability. In contrast, copper-based reactions offer several advantages: it is cost-effective, less toxic, earth-abundant, biocompatible, and environmentally benign, while minimizing the formation of undesired byproducts. This transformation enables the streamline synthesis of pharmacologically relevant heterocycles and alkaloids, offering access to bioactive molecules with enhanced therapeutic potential. This review highlights recent advances in design, mechanistic insights, and synthetic applications of copper-mediated C─H amination in medicinal chemistry. Particular emphasis is placed on its role in the construction of complex nitrogen frameworks and its integration into drug discovery and development. In addition, emerging approaches such as electrochemical C─H amination are discussed, demonstrating how these greener and more sustainable methodology can further reduce environmental impact while maintaining synthetic efficiency. By bridging the disciplines of transition-based synthesis and medicinal chemistry, this review underscores the pivotal role of copper in advancing next-generation, sustainable synthetic methodologies and inspiring future innovations in amine-based drug discovery.